LGVN MEXC RealStocks
Own real LGVN shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-16 12:13:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Longeveron Inc. (LGVN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.45, with a market capitalization of $8.40M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.31 to $12.30. This page covers its latest market performance, valuation, price trends and company information.
$8.40M | |
$2.45 | |
$2.45 | |
$2.45 | |
$2.49 | |
44.00 | |
119.64K | |
-- | |
$12.30 | |
$1.31 | |
-- | |
-- |
Longeveron Inc. (LGVN) is trading at $2.45 in pre-market trading as of 2026-11-16 12:01:00, down 1.61% ($0.04) from the previous close of $2.49
Pre-market trading shows how investors are pricing LGVN before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.
Over the past seven days, Longeveron Inc. (LGVN) moved from $1.71 to $2.45, representing a gain of 43.27% ($0.74).
The stock traded between $1.66 and $3.30 during the period. The latest price is near the middle of the 7-day range, indicating strong upward.
The average daily volume was 164.76 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 10.4%
LGVN is currently trading at $2.45, placing it 10.4% of the way from its 52-week low of $1.31 to its 52-week high of $12.30. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 38 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Longeveron Inc. (LGVN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to LGVN, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between LGVN shares and USD.
LGVN Shares to USD
1.00 LGVN shares = 2.45 USD
Calculations are estimates based on the latest available price and are for reference only.